Miyuki Sugimoto

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 37 citations · Full text

Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

Daisuke Minakata, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · International Journal of Hematology · 2018 · 36 citations

Thrombosis, Venous Thrombosis, Laboratory Hematology +12

Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan

Miyuki Sugimoto, Shoko Ito, Kiyomi Mashima et al. · Annals of Hematology · 2016 · 26 citations

Meam Regimen, Lymphoid Neoplasia, Hematological Malignancy +10

Effects of troglitazone on dexamethasone-induced insulin resistance in rats

Shoji Okumura, Noriyuki Takeda, Kazuhisa Takami et al. · Metabolism · 1998 · 23 citations

Insulin Resistance, Metabolic Syndrome, Molecular Pharmacology +9

Evaluation of thrombotic events in patients with immune thrombocytopenia

Shoko Ito, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · Annals of Hematology · 2019 · 22 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +8